Antibiotic Use in Patients with Constipation

Introduction to Constipation and Antibiotics

Antimotility agents, such as loperamide, and opiates should be avoided in patients with constipation, especially when there is concern for infectious diarrhea or C. difficile infection, as they can worsen ileus and potentially lead to toxic megacolon 1
The American Gastroenterological Association suggests that clindamycin and lincomycin are associated with severe antibiotic-associated colitis, including C. difficile infection, which can present with alternating diarrhea and constipation 2, 3

Fluoroquinolones, such as ciprofloxacin, levofloxacin, and ofloxacin, can cause both diarrhea and constipation as gastrointestinal side effects, and alternative agents should be considered when treating infections in patients with baseline constipation 4
The development of constipation or diarrhea alternating with constipation in patients being treated for C. difficile infection should raise concern for treatment failure or severe disease progression, according to the Infectious Diseases Society of America 2, 3

Constipation developing during C. difficile treatment may indicate ileus, toxic megacolon, or treatment failure requiring escalation to vancomycin or surgical consultation, as recommended by the Society for Healthcare Epidemiology of America 1
Loperamide and other antimotility agents must be avoided in patients with constipation, especially when infection is suspected, as they can precipitate or worsen ileus 1

Opiates should be avoided as they significantly impair gut motility and worsen constipation, particularly in the setting of infectious colitis or C. difficile infection 1
The European Society for Clinical Nutrition and Metabolism recommends increasing fluid intake (≥1.5 L/day) and dietary fiber from fruits, vegetables, and whole grains to help manage constipation 6
Consider fiber supplements or medications if dietary measures fail, as suggested by the American College of Gastroenterology 6

Post-bariatric surgery patients are at higher risk for both diarrhea and constipation, and antibiotic selection should account for altered gut anatomy and motility, according to the American Society for Metabolic and Bariatric Surgery 6
Patients with chronic intestinal pseudo-obstruction (CIPO) should avoid antibiotics causing constipation, and may require sequential antibiotic therapy for bacterial overgrowth, preferring poorly absorbable agents like rifaximin, as recommended by the European Society of Gastrointestinal Motility 7